When analyzed within IDH-mutant gliomas, however, NF1 and PTEN expression did not confer a survival advantage (Figure S1B), suggesting that their correlation with improved survival is associated with IDH mutation-mediated increase in gene expression. The gene discussed is IDH2; the disease is central nervous system cancer.